Medreich plc and Medreich Ltd
Meiji Group
Meiji Group
1167554
2022
20220203
competition-related offences
Warning: Undefined array key "offence_type" in /usr/home/goodjobsfirst/public_html/Live-UK-ViolationTracker/function.php on line 348
Alliance Pharmaceuticals Limited and Alliance Pharma plc, Focus Pharmaceuticals Limited, Focus Pharma Holdings Limited, Mercury Pharma Group Limited, Concordia Investment Holdings (UK) Limited, Concordia Investments (Jersey) Limited and Advanz Pharma Corp. Limited, Cinven Capital Management (V) General Partner Limited, Cinven (Luxco 1) S.A .r.l and Cinven Partners LLP, Lexon (UK) Limited and Lexon UK Holdings Limited, Medreich plc, Medreich Ltd, Meiji Seika Pharma Co. Ltd and Meiji Holdings Co. Ltd. were fined by the CMA following an investigation finding that the companies engaged in anti-competitive behaviour to increase the price of the drug prochlorperazine. Medreich's fine had a 40% leniency reduction for cooperating with the investigation.
agency action
Settlement and Leniency agreement with CMA
UK-CMA
Competition and Markets Authority
Japan
publicly traded
food products
food and pharmaceuticals
JP3918000005
https://www.gov.uk/government/news/cma-fines-firms-over-35m-for-illegal-arrangement-for-nhs-drug
UK21-68596
Medreich plc and Medreich Ltd and Meiji Seika Pharma Co. Ltd and Meiji Holdings Co. Ltd.
Meiji Group
Meiji Group
3452446
2022
20220203
competition-related offences
Warning: Undefined array key "offence_type" in /usr/home/goodjobsfirst/public_html/Live-UK-ViolationTracker/function.php on line 348
Alliance Pharmaceuticals Limited and Alliance Pharma plc, Focus Pharmaceuticals Limited, Focus Pharma Holdings Limited, Mercury Pharma Group Limited, Concordia Investment Holdings (UK) Limited, Concordia Investments (Jersey) Limited and Advanz Pharma Corp. Limited, Cinven Capital Management (V) General Partner Limited, Cinven (Luxco 1) S.A .r.l and Cinven Partners LLP, Lexon (UK) Limited and Lexon UK Holdings Limited, Medreich plc, Medreich Ltd, Meiji Seika Pharma Co. Ltd and Meiji Holdings Co. Ltd. were fined by the CMA following an investigation finding that the companies engaged in anti-competitive behaviour to increase the price of the drug prochlorperazine. Medreich's fine had a 40% leniency reduction for cooperating with the investigation.
agency action
Settlement and Leniency agreement with CMA
UK-CMA
Competition and Markets Authority
Japan
publicly traded
food products
food and pharmaceuticals
JP3918000005
https://www.gov.uk/government/news/cma-fines-firms-over-35m-for-illegal-arrangement-for-nhs-drug
UK21-68598
2